Nana Kwatemaa

发表

AMD3100 is a potent antagonist at CXCR4R334X, a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome

D. McDermott, H. Malech, P. Murphy, 2011, Journal of cellular and molecular medicine.

The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.

T. Fleisher, D. Kuhns, D. McDermott, 2011, Blood.

Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency

L. Notarangelo, J. Puck, S. S. De Ravin, 2022, Nature Communications.

Chromothriptic Cure of WHIM Syndrome

M. Raffeld, S. Pittaluga, Z. Dai, 2015, Cell.

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor.

S. Pittaluga, T. Fleisher, D. Kuhns, 2014, Blood.

Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency

L. Notarangelo, J. Gray, D. Kuhns, 2016, Science Translational Medicine.

Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial

S. Holland, D. Kuhns, C. Zerbe, 2017, Journal of Clinical Immunology.

Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report

N. Theobald, H. Malech, E. Kang, 2015, Journal of Clinical Immunology.

Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease

S. Holland, C. Zerbe, N. Theobald, 2020, Journal of Clinical Immunology.

Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report

N. Theobald, H. Malech, E. Kang, 2015, Journal of Clinical Immunology.

The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.

T. Fleisher, D. Kuhns, H. Malech, 2011, Blood.

Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial

S. Holland, D. Kuhns, C. Zerbe, 2017, Journal of Clinical Immunology.